Live Quote · NASDAQVYGRHealthcare· Biotechnology

Voyager Therapeutics, Inc.

$3.78 5.00%(+$0.18)
TickerSpark Score
47/100
Weak
70
Valuation
20
Profitability
10
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VYGR research report →

52-Week Range34% of range
Low
$2.88
Current
$3.78
High
$5.55

About the company

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease.

CEO
Alfred W. Sandrock Jr.
IPO
2015
Employees
172
HQ
Lexington, MA, US

Price Chart

+18.12% · this period
$5.33$4.14$2.96Jul 02Dec 31Jul 02
Valuation
Market Cap
$228.39M
P/E
-1.91
P/S
6.26
P/B
1.29
EV/EBITDA
-1.95
Div Yield
0.00%
Profitability
Gross Margin
-86.68%
Op Margin
-349.16%
Net Margin
-319.61%
ROE
-55.97%
ROIC
-60.90%
Growth & Income
Revenue
$40.37M · -49.53%
Net Income
$-119,721,000 · -84.18%
EPS
$-2.04 · -80.53%
Op Income
$-131,844,000
FCF YoY
-617.24%
Performance & Tape
52W High
$5.55
52W Low
$2.88
50D MA
$3.73
200D MA
$4.07
Beta
1.25
Avg Volume
581.25K

Get TickerSpark's AI analysis on VYGR

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 9, 26SCANGOS GEORGE Aother30,000
Jun 9, 26MACKEY CATHERINE Jother30,000
Jun 9, 26Hyman Stevenother30,000
Jun 9, 26Vitale Nancyother30,000
Jun 9, 26Higgins Michael Jother30,000
Jun 9, 26Onyia Judeother30,000
Jun 9, 26GERAGHTY JAMES Aother30,000
Jun 9, 26Colon Graceother30,000
Jun 9, 26PIERCE GLENNother30,000
May 8, 26Quinlan Amyother0
Coverage · VYGR

Our VYGR coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VYGR yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VYGR report →
Internal Compare

Similar companies

Peers in the same neighborhood.